JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Multz, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Multz, A. S.
Related Collections
Right arrow Critical Care
Right arrow Pharmacology

Anesth Analg 2003;96:1054-1055
© 2003 International Anesthesia Research Society

ANESTHETIC PHARMACOLOGY

Prolonged Dexmedetomidine Infusion as an Adjunct in Treating Sedation-Induced Withdrawal

Alan S. Multz, MD

Long Island Jewish Medical Center, New Hyde Park, New York

Address correspondence and reprint requests to Alan S. Multz, MD, Medical ICU, Long Island Jewish Medical Center, 270-05 76th Ave., New Hyde Park, NY 11040. Address e-mail to amultz{at}lij.edu

IMPLICATIONS: Dexmedetomidine, an {alpha}2-adrenoceptor agonist, is indicated for sedating patients on mechanical ventilation. It has been approved by the Food and Drug Administration for 24-h use. This is a report concerning a patient in whom a continuous infusion of dexmedetomidine was safely used for a week to help in averting frank withdrawal symptoms from an opioid and benzodiazepines.




This article has been cited by other articles:


Home page
 Journal of Pharmacy PracticeHome page
M. Klimek and M. M. Lacroix
The Safety and Effectiveness of Dexmedetomidine When Used for More Than 24 Hours in an Adult Intensive Care Setting
Journal of Pharmacy Practice, December 1, 2007; 20(6): 474 - 477.
[Abstract] [PDF]

Home page
 Br J AnaesthHome page
N. K. Girgin, R. Iscimen, A. Gurbet, F. Kahveci, and O. Kutlay
Dexmedetomidine sedation for the treatment of tetanus in the intensive care unit
Br. J. Anaesth., October 1, 2007; 99(4): 599 - 600.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. T Gerlach and J. F Dasta
Dexmedetomidine: An Updated Review
Ann. Pharmacother., February 1, 2007; 41(2): 245 - 252.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
K. Baddigam, P. Russo, J. Russo, and J. D. Tobias
Dexmedetomidine in the Treatment of Withdrawal Syndromes in Cardiothoracic Surgery Patients
J Intensive Care Med, March 1, 2005; 20(2): 118 - 123.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. F Dasta, S. L Kane-Gill, and A. J Durtschi
Comparing Dexmedetomidine Prescribing Patterns and Safety in the Naturalistic Setting Versus Published Data
Ann. Pharmacother., July 1, 2004; 38(7): 1130 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. C. Finkel and A. Elrefai
The Use of Dexmedetomidine to Facilitate Opioid and Benzodiazepine Detoxification in an Infant
Anesth. Analg., June 1, 2004; 98(6): 1658 - 1659.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.